Drug Class
antibody-drug conjugate
Type
brand
Active Ingredient
trastuzumab
📋Overview
Enhertu is a targeted cancer therapy known as an antibody-drug conjugate. It is primarily used in the management of certain types of breast cancer that express the HER2 protein. The medication works by delivering chemotherapy directly to cancer cells, aiming to limit damage to healthy cells. Enhertu is also being studied for its potential use in other HER2-positive cancers, such as gastric cancer.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Enhertu
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.